VU University Medical Center
Amsterdam, North Holland, 1081 HV, Netherlands
NCT Number: NCT03380338
To investigate whether targeted lifestyle intervention (exercise), induces a change in intestinal fecal microbiota related to improved glycemic control and systemic inflammation in patients with DM type 2.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Amsterdam, North Holland, 1081 HV, Netherlands
Diet and exercise are the most beneficial lifestyle interventions in patients with diabetes mellitus (DM) type 2, causing an increase in glucose tolerance.
One of the mechanisms through which these treatment modalities work might be explained through changes in the gut microbiota. Recent studies show that the chronic inflammatory status causing insulin resistance in DM type 2, is triggered by an increase in circulating bacterial lipopolysaccharide (LPS). Strict lifestyle intervention, such as exercise, so called Diabetes Bootcamp (DB), may manipulate the gut microbiota, reducing circulating LPS, causing an improvement of the insulin-mediated
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline, after 7 weeks, after 13 weeks
alfa-diversity, beta-diversity
Time frame: Before and after exercise, i.e. from first visit (0 weeks) untill last visit (13 weeks)
Rate of disappearance measured by the hyperinsulinemic-euglycemic clamp with stable glucose isotopes.
Time frame: Before and after exercise, i.e. from first visit (0 weeks) untill last visit (13 weeks)
Insulin-induced capillary recruitment in skeletal muscle and heart
Time frame: Before and after exercise
Indirect calorimetry
Time frame: Before and after exercise
Amsterdam UMC, location VUmc
Other
Lifestyle Intervention in Patients With Diabetes Type 2 and the Association With the Gut Microbiota
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06362265
Diabetes Mellitus, Diabetes Mellitus, Type 2
Los Angeles, California, United States
View Trial DetailsNCT02227849
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chūbu, Japan
View Trial DetailsNCT02622113
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial DetailsNCT02220920
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chugoku, Japan
View Trial Details